The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Editorial Policy and Advisory Group
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Frontiers in Oncology
(Oct 2023)
Editorial: New therapeutics for soft tissue sarcomas
Marla Weetall,
Mark Rance,
Matthew Ingham,
Brian A. Van Tine,
Brian A. Van Tine,
Brian A. Van Tine
Affiliations
Marla Weetall
Pharmacology and Biomarkers, PTC Therapeutics (United States), South Plainfield, NJ, United States
Mark Rance
Pharmacology and Biomarkers, PTC Therapeutics (United States), South Plainfield, NJ, United States
Matthew Ingham
Clinical Development, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States
Brian A. Van Tine
Division of Medical Oncology, Washington University in St. Louis, St. Louis, MO, United States
Brian A. Van Tine
Siteman Cancer Center, St. Louis, MO, United States
Brian A. Van Tine
Division of Pediatric Hematology and Oncology, St. Louis Children's Hospital, St. Louis, MO, United States
DOI
https://doi.org/10.3389/fonc.2023.1297215
Journal volume & issue
Vol. 13
Abstract
Read online
No abstracts available.
Keywords
sarcoma
combination (combined) therapy
chemotherapy
immunotherapy
personalized medicine
WeChat QR code
Close